通过大规模匹配分子对分析,对P-糖蛋白介导的外流进行动性建模
1Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
European journal of medicinal chemistry
|September 29, 2023
概括
了解P-glycoprotein (Pgp) 排泄是药物开发的关键. 提高被动透性提供了一种减轻Pgp介导药物耐药性和改善药物输送的策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
背景情况:
- P-glycoprotein (Pgp) 流出显著影响药物ADME特性,并有助于癌症多药耐药性.
- 了解基质-Pgp相互作用对于预测和克服流出挑战至关重要.
研究的目的:
- 阐明基质特性与Pgp介导的流动之间的机械关系.
- 评估基于规则的方法和物理化学性质,以缓解流失的策略.
- 要突出被动透性在克服Pgp排泄中的作用.
主要方法:
- 动态建模分析基质-Pgp相互作用和流出机制.
- 匹配的分子对分析,以评估 efflux 的结构-活动关系.
- 对包括PROTACs在内的各种化合物类的物理化学性质分析.
主要成果:
- 动力建模弥合了极性PGP基板和疏水性结合部位之间的差距.
- 基于规则的方法 (例如,H-债券捐赠者,极地表面积) 显示出对流量缓解的局限性.
- 增加内在的被动透性是降低流出比率的关键因素.
- 与符合五项规则的化合物相比,PROTACs具有独特的物理化学特性,以逃避排泄.
结论:
- 将被动透性与特定基质-Pgp相互作用分开,对于合理的药物设计至关重要.
- 提高被动透性的策略对于减轻Pgp介导的流量至关重要.
- 需要更深入的机制理解来设计能够有效避开PGP排泄的药物.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
61
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
89
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
89
Carrier-Mediated Transport
460
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
460
Protein-Drug Binding: Mechanism and Kinetics
561
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
561
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
87
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
87
Pharmacokinetic Models: Comparison and Selection Criterion
96
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
96


